Read More Pharma Industry News Compugen initiates Phase 1 trial of COM701 cancer immunotherapy in advanced solid tumors Israeli pharmaceutical company Compugen has announced the commencement of a phase 1 clinical trial for its innovative cancer… bypharmanewsdailySeptember 8, 2018